Lumos Pharma, Inc. (LUMO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lumos Pharma, Inc., with annual and quarterly history.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.76x | -0.97x | -1.90x | -42.74x | -2.19x | -1.05x |
| P/B Ratio | 0.95x | 0.51x | 0.65x | 2.08x | 1.19x | 0.49x |
| P/S Ratio | 12.63x | 19.85x | 251.12x | 1440.71x | 100.70x | 46.87x |
| Profitability | ||||||
| Gross Margin | 100.0% | 96.8% | 100.0% | 100.0% | 96.0% | 1034.3% |
| Operating Margin | -1785.2% | -2103.7% | -13629.1% | -15656.5% | -4822.0% | -5177.3% |
| Net Margin | -1659.4% | -2039.5% | -13230.4% | -3370.8% | -4592.8% | -4444.0% |
| EBITDA Margin | -1783.0% | -2100.5% | -13534.8% | -15308.9% | -1032.9% | -4922.6% |
| Liquidity | ||||||
| Current Ratio | 5.69x | 10.73x | 19.43x | 19.88x | 7.98x | 14.36x |
| Quick Ratio | 5.69x | 10.73x | 19.43x | 19.88x | 7.98x | 14.36x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.00x | 0.01x | 0.00x | 0.02x | 0.00x |
YoY = year-over-year change. Source: FMP..